ROYAL BANK OF CANADA - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 75 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 443.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$36,000
+80.0%
11,215
+112.5%
0.00%
Q2 2023$20,000
+81.8%
5,277
+28.4%
0.00%
Q1 2023$11,000
-8.3%
4,109
-40.8%
0.00%
Q4 2022$12,000
+1100.0%
6,945
+1095.4%
0.00%
Q3 2022$1,0000.0%581
+115.2%
0.00%
Q2 2022$1,000
-88.9%
270
-87.1%
0.00%
Q1 2022$9,0002,0970.00%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders